发明名称 Crotoxin Administration for Cancer Treatment
摘要 A method for treating cancer using an intra-patient dose escalation procedure to deliver dosages of Crotalus durissus terrificus venom.
申请公布号 US2015110770(A1) 申请公布日期 2015.04.23
申请号 US201414586560 申请日期 2014.12.30
申请人 Celtic Biotech Iowa, Inc. 发明人 Reid Paul F.
分类号 A61K38/46;A61K35/583;A61K45/06 主分类号 A61K38/46
代理机构 代理人
主权项 1. A method for treating cancer comprising: administering to a cancer patient at least one Crotalus durissus terrificus venom dosage of from about 0.04 to about 0.8 mg, the dosage being intravenously administered in an intra-patient dose escalation procedure, the intra-patient dose escalation procedure comprising consecutive administration of: about 0.04 mg/day for a 3-5 day treatment period; about 0.08 mg/day for a 3-5 day treatment period; about 0.12 mg/day for a 3-5 day treatment period; about 0.16 mg/day for a 3-5 day treatment period; about 0.2 mg/day for a 3-5 day treatment period; about 0.24 mg/day for a 3-5 day treatment period; about 0.28 mg/day for a 3-5 day treatment period; about 0.32 mg/day for a 3-5 day treatment period; about 0.36 mg/day for a 3-5 day treatment period; about 0.4 mg/day for a 3-5 day treatment period; about 0.44 mg/day for a 3-5 day treatment period; about 0.48 mg/day for a 3-5 day treatment period; about 0.52 mg/day for a 3-5 day treatment period; about 0.56 mg/day for a 3-5 day treatment period; about 0.6 mg/day for a 3-5 day treatment period; about 0.64 mg/day for a 3-5 day treatment period; about 0.68 mg/day for a 3-5 day treatment period; about 0.72 mg/day for a 3-5 day treatment period; about 0.76 mg/day for a 3-5 day treatment period; and about 0.8 mg/day for a 3-5 day treatment period; and wherein each successive dose escalation is conditioned upon the absence of dose-limiting toxicity from the previous dose.
地址 West Des Moines IA US